Pregnenolone in the Management of Schizophrenia Patients

This study has been completed.

Study NCT00174889 Information provided by Sha’ar Menashe Mental Health Center

First Received: September 9, 2005 Last Updated: May 20, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	May 2007
Estimated Primary Completion Date:	No date given

No publications provided by Sha’ar Menashe Mental Health Center

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Ritsner MS, Gibel A, Shleifer T, Boguslavsky I, Zayed A, Maayan R, Weizman A, Lerner V. Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J Clin Psychiatry. 2010 Oct;71(10):1351-62. Epub 2010 Jun 15.